Natasha Persaud

Serum beta-2 microglobulin can be used to monitor kidney damage in systemic lupus erythematosus for earlier diagnosis of lupus nephritis.

Hyperuricemia is frequently observed among patient with chronic kidney disease.

Latest findings are from a post hoc meta-analysis of pooled data from the DAPA-HF and DELIVER trials.

Underperforming organ procurement organizations may be contributing to the nationwide organ shortage, investigators suggest.

A higher serum uric acid to HDL ratio may indicate a greater preclinical inflammatory burden, according to investigators.

Investigators examined the association between uric acid levels and all-cause and cardiovascular mortality in patients with diabetes in a national population-based sample and 13 cohort studies.

In addition to cardiovascular disease, gout is associated with an increased risk of dying from genitourinary conditions, such as chronic kidney disease.

Patients receiving significant amount of immunosuppression prior to kidney transplantation should be counseled on these malignancy risks, according to investigators.

The ABCG2 transporter drives urate excretion in the kidney and intestine.

Patients with advanced CKD have not been well-represented in trials evaluating intensive blood pressure control.

Reducing tumor necrosis factor alpha production using infliximab induction did not improve clinical outcomes in kidney transplant recipients.

Early identification of patients at high risk of hyperuricemia using the triglyceride-glucose index may permit prompt intervention.

Gout patients are susceptible to breakthrough COVID-19 infection and severe outcomes despite vaccination.

Early diagnosis and treatment of childhood-onset systemic lupus erythematosus is important to prevent lupus nephritis outcomes such as end-stage kidney disease.

With further validation, the artificial neural network may be used in clinical practice for lupus nephritis management.

One study focused on patients with severe lupus nephritis, who are at greatest risk for kidney failure.

Belimumab treatment continued to protect the kidneys in adults with active lupus nephritis.

In a study of 121 patients with lupus nephritis on dialysis, 26.4% experienced an SLE flare at a median of 17 months after dialysis initiation.

Risk of fracture at specific sites differed by cause of kidney failure, investigators found.

Clinicians currently decide whether or not to prescribe urate-lowering therapies in patients with asymptomatic hyperuricemia.

Hypertension is prevalent among patients with lupus nephritis, especially in those with proliferative disease, investigators noted.

Each of the 4 potassium binders that were compared in a study had advantages and disadvantages, investigators reported.

Clinicians are increasingly using dietary protein and exercise interventions during hemodialysis to help maintain patients’ muscle strength.

Some patients with SLE and low-grade proteinuria may have early active lupus nephritis.

Improving health literacy may offer a way to prevent adverse clinical outcomes in chronic kidney disease.

Vitamin D deficiency and secondary hyperparathyroidism are associated with more rapid bone decline in older men.

Patients with gout flare have increased odds of cardiovascular events, independent of traditional cardiovascular risk factors.

Even women meeting objective criteria for CKD and nephrology referral were disadvantaged, according to investigators.

New findings raise questions about the reliability of estimated glomerular filtration rate as a basis for clinical decision-making.

Salt substitutes commonly contain potassium chloride.